HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZHAOKE OPHTH-B

3.760

+0.1604.44%

Volume:6.87M

Turnover:25.72M

Market Cap:2.06B

PE:-7.91

High:3.920

Open:3.580

Low:3.580

Close:3.600

Loading ...

Overview Company News Filings

Zhaoke Ophthalmology Gets Registration Certificate for Tonometer in China

MT Newswires Live

BRIEF-Zhaoke Ophthalmology Obtains Registration For Tono-I Device From NMPA

ZHAOKE OPHTH-B (06622) Obtains Medical Device Registration Certificate from NMPA for TONO-i Eye Pressure Measurement Device

Zhaoke Ophthalmology - Obtains Registration for Tono-I Device From Nmpa

THOMSON REUTERS

Zhaoke Secures US FDA Orphan Drug Status for Pediatric Eye Cancer Drug; Shares Lose 1%

MT Newswires Live

Zhaoke Ophthalmology Ltd. Receives FDA Orphan Drug Designation for Melphalan Targeting Pediatric Retinoblastoma

Zhaoke Ophthalmology - US FDA Grants Orphan Drug Designation to Zhaoke's Melphalan

THOMSON REUTERS

Zhaoke Ophthalmology Ltd. Announces NMPA Acceptance of New Drug Application for NVK002 to Combat Myopia Progression in Children

Zhaoke Ophthalmology Ltd. Announces Changes to Nomination Committee Composition

Zhaoke Ophthalmology Ltd. Announces NMPA Acceptance of Biologics License Application for TAB014 for wAMD Treatment

Zhaoke Ophthalmology Ltd. Secures FDA Clearance for IND Application of CsA Ophthalmic Gel for Dry Eye Disease Treatment

BRIEF-Zhaoke Ophthalmology Announces NMPA Acceptance Of New Drug Application For Cyclosporine (Csa) Ophthalmic Gel

Zhaoke Ophthalmology's New Drug Application for Dry Eye Gel Accepted by Chinese Regulator

MT Newswires Live

Zhaoke Ophthalmology Ltd. Announces NMPA Acceptance of New Drug Application for CsA Ophthalmic Gel for Dry Eye Disease

Zhaoke Ophthalmology Ltd. Conducted Annual General Meeting

Zhaoke Ophthalmology Enrols First Patient in Dry Eye Disease Drug Trial

MT Newswires Live

Zhaoke Ophthalmology, Interpharma Strike Thailand Drug Distribution Deal

MT Newswires Live

BRIEF-Zhaoke Ophthalmology Enters 3 Distribution Agreements With Interpharma

Zhaoke Ophthalmology Shrinks Loss in 2024

MT Newswires Live

Stock Track | Zhaoke Ophthalmology Plummets 6.51% Following Annual Loss of RMB237.5 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/06622/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06622","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06622\",,,,,undefined,":{"symbol":"06622","market":"HK","secType":"STK","nameCN":"ZHAOKE OPHTH-B","latestPrice":3.76,"timestamp":1754467709743,"preClose":3.6,"halted":0,"volume":6870802,"delay":0,"floatShares":548000000,"shares":548000000,"eps":-0.47511485415538235,"marketStatus":"Not Yet Opened","change":0.16,"latestTime":"08-06 16:08:29","open":3.58,"high":3.92,"low":3.58,"amount":25724093,"amplitude":0.094444,"askPrice":3.77,"askSize":45000,"bidPrice":3.76,"bidSize":18500,"shortable":0,"etf":0,"ttmEps":-0.47511485415538235,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1754530200000},"marketStatusCode":0,"adr":0,"listingDate":1619625600000,"exchange":"SEHK","adjPreClose":3.6,"openAndCloseTimeList":[[1754443800000,1754452800000],[1754456400000,1754467200000]],"volumeRatio":1.3563388668180745,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06622\",,,,,undefined,":{"symbol":"06622","floatShares":548000000,"roa":"-8.02%","roe":"-12.03%","lyrEps":-0.475115,"volumeRatio":1.3563388668180745,"shares":548000000,"dividePrice":0,"high":3.92,"amplitude":0.094444,"preClose":3.6,"low":3.58,"week52Low":1.2,"pbRate":"0.99","psRate":"27.20","week52High":3.92,"institutionHeld":0,"latestPrice":3.76,"committee":-0.417323,"eps":-0.47511485415538235,"divideRate":0,"volume":6870802,"delay":0,"ttmEps":-0.47511485415538235,"open":3.58,"prevYearClose":1.2,"prevWeekClose":2.86,"prevMonthClose":2.99,"prevQuarterClose":2.6,"fiveDayClose":3.11,"twentyDayClose":2.55,"sixtyDayClose":1.71},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06622\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2556811387","title":"Zhaoke Ophthalmology Gets Registration Certificate for Tonometer in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2556811387","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556811387?lang=en_us&edition=fundamental","pubTime":"2025-08-04 20:21","pubTimestamp":1754310065,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology (HKG:6622) obtained a medical device registration certificate for TONO-i from China's National Medical Products Administration, a Monday Hong Kong bourse filing said.TONO-i is a tonometer designed to be contactless, portable, and convenient.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","06622","BK1587","BK1583","BK1191"],"gpt_icon":0},{"id":"2556884303","title":"BRIEF-Zhaoke Ophthalmology Obtains Registration For Tono-I Device From NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2556884303","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556884303?lang=en_us&edition=fundamental","pubTime":"2025-08-04 18:37","pubTimestamp":1754303866,"startTime":"0","endTime":"0","summary":"BRIEF-Zhaoke Ophthalmology Obtains Registration For Tono-I Device From NMPAAug 4 (Reuters) - Zhaoke Ophthalmology Ltd 6622.HK:OBTAINS REGISTRATION FOR TONO-I DEVICE FROM NMPAFurther company coverage: 6622.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nFWN3TW0PE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1587","BK1191","BK1574","06622"],"gpt_icon":0},{"id":"1120166434","title":"ZHAOKE OPHTH-B (06622) Obtains Medical Device Registration Certificate from NMPA for TONO-i Eye Pressure Measurement Device","url":"https://stock-news.laohu8.com/highlight/detail?id=1120166434","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120166434?lang=en_us&edition=fundamental","pubTime":"2025-08-04 17:50","pubTimestamp":1754301028,"startTime":"0","endTime":"0","summary":"ZHAOKE OPHTH-B (06622) announced that the company has obtained a medical device registration certificate from the National Medical Products Administration (NMPA) for TONO-i. TONO-i is an innovative...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","06622","159883","BK1587","BK1583","BK1222","09997","09996","BK1100","BK1191"],"gpt_icon":0},{"id":"2556807601","title":"Zhaoke Ophthalmology - Obtains Registration for Tono-I Device From Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2556807601","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556807601?lang=en_us&edition=fundamental","pubTime":"2025-08-04 17:45","pubTimestamp":1754300758,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nFWN3TW0PE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1587","06622","BK1574","BK1191"],"gpt_icon":0},{"id":"2555907061","title":"Zhaoke Secures US FDA Orphan Drug Status for Pediatric Eye Cancer Drug; Shares Lose 1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555907061","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555907061?lang=en_us&edition=fundamental","pubTime":"2025-07-31 12:41","pubTimestamp":1753936915,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology  said its proprietary formulation of melphalan has received orphan drug designation from the US Food and Drug Administration for the treatment of pediatric retinoblastoma, according to a Wednesday bourse filing.Shares of the company declined by over 1% in Thursday's recent trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","BK1574","BK1587","06622","BK1191"],"gpt_icon":0},{"id":"2555045807","title":"Zhaoke Ophthalmology Ltd. Receives FDA Orphan Drug Designation for Melphalan Targeting Pediatric Retinoblastoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2555045807","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555045807?lang=en_us&edition=fundamental","pubTime":"2025-07-30 19:10","pubTimestamp":1753873837,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology Ltd. has announced that the U.S. Food and Drug Administration  has granted Orphan Drug Designation  to its proprietary formulation of melphalan for the treatment of pediatric retinoblastoma, a rare pediatric eye cancer. This designation provides a clear regulatory pathway toward the submission of an Investigational New Drug  application in the U.S. If successfully developed and approved, Zhaoke Ophthalmology Ltd. would be eligible for seven years of market exclusivity in the U.S. upon New Drug Application  approval. This exclusivity includes marketing authorization holder status and data exclusivity, offering comprehensive protection in the market.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhaoke Ophthalmology","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250730:nNDL2KYNbP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","BK1587","06622","BK1574"],"gpt_icon":0},{"id":"2555043263","title":"Zhaoke Ophthalmology - US FDA Grants Orphan Drug Designation to Zhaoke's Melphalan","url":"https://stock-news.laohu8.com/highlight/detail?id=2555043263","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555043263?lang=en_us&edition=fundamental","pubTime":"2025-07-30 19:06","pubTimestamp":1753873599,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250730:nFWN3TR11G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1587","BK1583","06622","BK1574"],"gpt_icon":0},{"id":"2550863931","title":"Zhaoke Ophthalmology Ltd. Announces NMPA Acceptance of New Drug Application for NVK002 to Combat Myopia Progression in Children","url":"https://stock-news.laohu8.com/highlight/detail?id=2550863931","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550863931?lang=en_us&edition=fundamental","pubTime":"2025-07-09 18:39","pubTimestamp":1752057561,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology Ltd. Announces NMPA Acceptance of New Drug Application for NVK002 to Combat Myopia Progression in Children. Zhaoke Ophthalmology Ltd. has announced that the National Medical Products Administration  of China has accepted the New Drug Application  for NVK002  for the treatment of myopia progression in children. This acceptance marks a significant step in the regulatory review process for this innovative drug, which is being reviewed as a Class II innovative drug. Previously, an Abbreviated New Drug Application  for a 0.01% formulation of the same drug was also accepted by the NMPA. The company aims to address the growing issue of myopia among children and adolescents in China, with this development aligning with the national health objectives outlined by the Chinese government.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated conte","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDL8DBtVS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622","BK1587","BK1574","BK1191","BK1583"],"gpt_icon":0},{"id":"2548562568","title":"Zhaoke Ophthalmology Ltd. Announces Changes to Nomination Committee Composition","url":"https://stock-news.laohu8.com/highlight/detail?id=2548562568","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548562568?lang=en_us&edition=fundamental","pubTime":"2025-07-02 12:09","pubTimestamp":1751429344,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology Ltd. has announced changes to its Nomination Committee, effective July 1, 2025. Mr. Wong Hin Wing, Prof. Lo Yuk Lam, and Ms. Leelalertsuphakun Wanee have been appointed as members, with Mr. Wong Hin Wing serving as the chairman. The committee now includes two independent non-executive directors and one non-executive director.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhaoke Ophthalmology Ltd. published the original content used to generate this news brief on July 02, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nNDLbRp05L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","BK1587","06622","BK1574"],"gpt_icon":0},{"id":"2542596399","title":"Zhaoke Ophthalmology Ltd. Announces NMPA Acceptance of Biologics License Application for TAB014 for wAMD Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2542596399","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542596399?lang=en_us&edition=fundamental","pubTime":"2025-06-12 16:41","pubTimestamp":1749717691,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology Ltd. has announced that the National Medical Products Administration  of China has accepted its Biologics License Application  for TAB014, a treatment for wet age-related macular degeneration . This marks the first submission of a bevacizumab-based antibody for wAMD in China. The application is supported by successful Phase III clinical trial results, which demonstrated the efficacy of TAB014 in improving best corrected visual acuity compared to Lucentis. The trial was a randomized, double-blind, non-inferiority study. Zhaoke Ophthalmology Ltd. has exclusive rights over the development and commercialization of TAB014 in China, Hong Kong, and Macau, while TOT BIOPHARM Co., Ltd. will handle manufacturing. The approval process underscores Zhaoke's commitment to advancing ophthalmic treatments in the region.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely informat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL1YwNrn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","01875","BK1574","BK1587","06622","BK1161","BK1191"],"gpt_icon":0},{"id":"2540705409","title":"Zhaoke Ophthalmology Ltd. Secures FDA Clearance for IND Application of CsA Ophthalmic Gel for Dry Eye Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2540705409","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540705409?lang=en_us&edition=fundamental","pubTime":"2025-06-04 18:08","pubTimestamp":1749031684,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology Ltd. has announced that the U.S. Food and Drug Administration  has cleared its Investigational New Drug  application for its core product, Cyclosporine  Ophthalmic Gel. This gel is being developed for the treatment of moderate-to-severe dry eye disease and will advance to a Phase III, multicenter, randomized, double-masked, active-controlled study. The FDA's clearance allows Zhaoke to incorporate data from its completed pivotal Phase III clinical trial  and ongoing Phase III trial in China into its U.S. development plan. This regulatory milestone marks a significant step forward for Zhaoke in potentially improving patient compliance and quality of life with its innovative once-daily application gel.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financia","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL9fqH1V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1587","BK1583","BK1574","06622"],"gpt_icon":0},{"id":"2536639238","title":"BRIEF-Zhaoke Ophthalmology Announces NMPA Acceptance Of New Drug Application For Cyclosporine (Csa) Ophthalmic Gel","url":"https://stock-news.laohu8.com/highlight/detail?id=2536639238","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536639238?lang=en_us&edition=fundamental","pubTime":"2025-05-20 00:53","pubTimestamp":1747673610,"startTime":"0","endTime":"0","summary":"BRIEF-Zhaoke Ophthalmology Announces NMPA Acceptance Of New Drug Application For Cyclosporine  Ophthalmic GelMay 19  - Zhaoke Ophthalmology Ltd 6622.HK:NMPA ACCEPTANCE OF NEW DRUG APPLICATION FOR CYCLOSPORINE  OPHTHALMIC GELFurther company coverage: 6622.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nFWN3RR096:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","06622","BK1587","BK1574"],"gpt_icon":0},{"id":"2536689724","title":"Zhaoke Ophthalmology's New Drug Application for Dry Eye Gel Accepted by Chinese Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=2536689724","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536689724?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:08","pubTimestamp":1747656510,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology's  new drug application for core product Cyclosporine  Ophthalmic Gel has been accepted by China's National Medical Products Administration, a Monday Hong Kong bourse filing said.The product is being developed by the ophthalmic pharmaceutical company in China for the treatment of moderate to severe dry eye disease.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK1574","06622","BK1583","BK1587"],"gpt_icon":0},{"id":"2536501460","title":"Zhaoke Ophthalmology Ltd. Announces NMPA Acceptance of New Drug Application for CsA Ophthalmic Gel for Dry Eye Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2536501460","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536501460?lang=en_us&edition=fundamental","pubTime":"2025-05-19 17:21","pubTimestamp":1747646463,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology Limited has announced that the National Medical Products Administration  of China has accepted the New Drug Application  for its Cyclosporine  Ophthalmic Gel. This gel is being developed for the treatment of moderate to severe dry eye disease. The acceptance follows comprehensive communication and a pre-NDA discussion with the NMPA, along with a written endorsement based on results from the Phase III clinical trial, known as the COSMO study, and further data analysis. The CsA Ophthalmic Gel, which is designed for once-daily application, demonstrated a rapid onset of action within two weeks in the trial, potentially improving patient compliance and quality of life. Zhaoke Ophthalmology cautions that commercialization is not guaranteed, and advises cautious trading of its shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated cont","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL4GNZ16:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1587","06622","BK1583","BK1191"],"gpt_icon":0},{"id":"2535397465","title":"Zhaoke Ophthalmology Ltd. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2535397465","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535397465?lang=en_us&edition=fundamental","pubTime":"2025-05-16 20:57","pubTimestamp":1747400265,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology Ltd. held its Annual General Meeting on May 16, 2025. During the meeting, a proposal to grant a general mandate to the Director of the Company to repurchase shares not exceeding 10% of the total number of issued shares was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhaoke Ophthalmology Ltd. published the original content used to generate this news brief on May 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDL2Wdgh4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","BK1587","06622","BK1191"],"gpt_icon":0},{"id":"2529874657","title":"Zhaoke Ophthalmology Enrols First Patient in Dry Eye Disease Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2529874657","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529874657?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:58","pubTimestamp":1745233118,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology  has enrolled the first patient in the phase III clinical trial of Cyclosporine  Ophthalmic Gel, an April 17 Hong Kong bourse filing said.The ophthalmic pharmaceutical company is testing the drug for the treatment of moderate to severe dry eye disease.The trial will involve 25 centers and enroll a total of 360 patients.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK1574","06622","BK1583","BK1587"],"gpt_icon":0},{"id":"2527292479","title":"Zhaoke Ophthalmology, Interpharma Strike Thailand Drug Distribution Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2527292479","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527292479?lang=en_us&edition=fundamental","pubTime":"2025-04-16 19:16","pubTimestamp":1744802199,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology  entered into three distribution and supply agreements with Interpharma PCL  to commercialize several ophthalmic drugs in Thailand, according to a Wednesday filing with the Hong Kong Exchange.The deals cover NVK002 for myopia progression control, BRIMOCHOL PF for presbyopia, and six generic glaucoma drugs: Bimatoprost, Bimatoprost Timolol, Latanoprost, Latanoprost Timolol, Travoprost, and Travoprost Timolol.Under the agreements, Interpharma gains exclusive rights to import, distribute, market, and sell Zhaoke's products in Thailand and will manage local drug registrations. Zhaoke will then receive non-refundable upfront payments and milestone-based payments.Shares of Interpharma closed nearly 5% higher on Wednesday, while those of Zhaoke slipped 3%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","06622","BK1191","BK1587","BK1574"],"gpt_icon":0},{"id":"2527635295","title":"BRIEF-Zhaoke Ophthalmology Enters 3 Distribution Agreements With Interpharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2527635295","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527635295?lang=en_us&edition=fundamental","pubTime":"2025-04-16 18:29","pubTimestamp":1744799368,"startTime":"0","endTime":"0","summary":"BRIEF-Zhaoke Ophthalmology Enters 3 Distribution Agreements With InterpharmaApril 16  - Zhaoke Ophthalmology Ltd 6622.HK:ENTERS 3 DISTRIBUTION AGREEMENTS WITH INTERPHARMA TO COMMERCIALIZE NVK002, BRIMOCHO TM PF & 6 GLAUCOMA DRUGS IN THAILANDFurther company coverage: 6622.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nFWN3QT2LO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1191","BK1574","06622","BK1583"],"gpt_icon":0},{"id":"2522048660","title":"Zhaoke Ophthalmology Shrinks Loss in 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2522048660","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522048660?lang=en_us&edition=fundamental","pubTime":"2025-03-25 17:46","pubTimestamp":1742895976,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology  shrank its attributable loss for the year 2024 to 237.5 million yuan from 385 million yuan in the year-ago period, a Monday filing with the Hong Kong bourse said.Loss per share stood at 0.43 yuan, down from 0.71 yuan in the corresponding period last year.The ophthalmic pharmaceutical company's revenue for the year increased to 69.3 million yuan from 18.8 million yuan a year prior, mainly due to a rise in licensing income.The firm attributed the lower loss mainly to a milestone payment received under a product license agreement, significant sales growth in key ophthalmic drug products, and lower R&D expenses.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1587","BK1583","BK1574","06622","BK1191"],"gpt_icon":0},{"id":"1108867802","title":"Stock Track | Zhaoke Ophthalmology Plummets 6.51% Following Annual Loss of RMB237.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1108867802","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108867802?lang=en_us&edition=fundamental","pubTime":"2025-03-25 09:33","pubTimestamp":1742866412,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology  saw its stock price plummet by 6.51% in pre-market trading on Tuesday, following the release of its annual financial results. The sharp decline comes as investors react to the company's substantial loss for the year.According to the financial report, Zhaoke Ophthalmology posted a loss of RMB237.5 million for the fiscal year. This significant loss appears to have shaken investor confidence, leading to the sell-off. The company also reported annual revenue of RMB69.3 million,","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Zhaoke Ophthalmology Plummets 6.51% Following Annual Loss of RMB237.5 Million","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["06622"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06622\",params:#limit:5,,,undefined,":[{"date":"2025-03-24","symbol":"06622","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post Market","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-29","symbol":"06622","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724895000000,"name":null,"time":"","dateTimestamp":1724860800000,"actualEps":null},{"date":"2024-03-27","symbol":"06622","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711503000000,"name":null,"time":"","dateTimestamp":1711468800000,"actualEps":null},{"date":"2023-08-23","symbol":"06622","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692754200000,"name":null,"time":"","dateTimestamp":1692720000000,"actualEps":null},{"date":"2023-03-27","symbol":"06622","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1679880600000,"name":null,"time":"","dateTimestamp":1679846400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06622\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06622\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1729612800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06622\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06622","date":"2025-08-05","current":-7.576628,"percent":0.033238,"low":-10.330575,"twenty":-4.791545,"median":-3.344795,"eighty":-1.216417,"high":-0.521441,"avg":-3.39836,"sd":2.037091,"marketCap":1966101019},"quantilePoints":[{"date":"2021-04-30","current":-7.671302,"twenty":-10.324351,"median":-9.553912,"eighty":-8.341094,"marketCap":6689443750},{"date":"2021-05-07","current":-6.951188,"twenty":-9.400654,"median":-7.729796,"eighty":-7.238147,"marketCap":6100772700},{"date":"2021-05-14","current":-6.967918,"twenty":-8.286758,"median":-7.195428,"eighty":-6.822045,"marketCap":6111475810},{"date":"2021-05-21","current":-7.490584,"twenty":-7.863628,"median":-7.195428,"eighty":-6.901971,"marketCap":6571709540},{"date":"2021-05-28","current":-7.731592,"twenty":-7.730873,"median":-7.212342,"eighty":-6.9232,"marketCap":6849990400},{"date":"2021-06-04","current":-8.266075,"twenty":-8.121175,"median":-7.475044,"eighty":-6.946253,"marketCap":7288809840},{"date":"2021-06-11","current":-7.634521,"twenty":-8.02236,"median":-7.634521,"eighty":-6.957805,"marketCap":6731430264},{"date":"2021-06-18","current":-7.194432,"twenty":-7.993943,"median":-7.490584,"eighty":-6.954496,"marketCap":6291957906},{"date":"2021-06-25","current":-7.738579,"twenty":-7.972772,"median":-7.503714,"eighty":-6.954496,"marketCap":6763586778},{"date":"2021-07-02","current":-7.088277,"twenty":-7.956306,"median":-7.475044,"eighty":-6.96773,"marketCap":6184391488},{"date":"2021-07-09","current":-6.687463,"twenty":-7.952849,"median":-7.364819,"eighty":-6.942963,"marketCap":5828842849},{"date":"2021-07-16","current":-6.897747,"twenty":-7.950142,"median":-7.240372,"eighty":-6.912222,"marketCap":6012004269},{"date":"2021-07-23","current":-5.934117,"twenty":-7.81976,"median":-7.194432,"eighty":-6.896601,"marketCap":5171616576},{"date":"2021-07-30","current":-4.928539,"twenty":-7.738579,"median":-7.107248,"eighty":-6.690075,"marketCap":4309680480},{"date":"2021-08-06","current":-4.922102,"twenty":-7.731592,"median":-6.996326,"eighty":-6.673965,"marketCap":4293658653},{"date":"2021-08-13","current":-4.90307,"twenty":-7.729796,"median":-6.967824,"eighty":-5.934117,"marketCap":4282884102},{"date":"2021-08-20","current":-1.222521,"twenty":-7.718309,"median":-6.950623,"eighty":-5.193866,"marketCap":3878838432},{"date":"2021-08-27","current":-1.234062,"twenty":-7.671302,"median":-6.916929,"eighty":-5.024583,"marketCap":3932711188},{"date":"2021-09-03","current":-1.368746,"twenty":-7.634521,"median":-6.910025,"eighty":-4.961865,"marketCap":4363693236},{"date":"2021-09-10","current":-1.331525,"twenty":-7.548256,"median":-6.897174,"eighty":-4.903998,"marketCap":4255947724},{"date":"2021-09-17","current":-1.294903,"twenty":-7.516844,"median":-6.840182,"eighty":-1.368746,"marketCap":4126653109},{"date":"2021-09-24","current":-1.311201,"twenty":-7.50813,"median":-6.690075,"eighty":-1.351642,"marketCap":4180525865},{"date":"2021-09-30","current":-1.268095,"twenty":-7.496731,"median":-6.682087,"eighty":-1.330403,"marketCap":4056618526},{"date":"2021-10-08","current":-1.246259,"twenty":-7.471936,"median":-6.459036,"eighty":-1.315075,"marketCap":3986583944},{"date":"2021-10-15","current":-1.223526,"twenty":-7.439312,"median":-6.053775,"eighty":-1.282983,"marketCap":3916549361},{"date":"2021-10-22","current":-1.199766,"twenty":-7.391342,"median":-5.527476,"eighty":-1.24887,"marketCap":3868063880},{"date":"2021-10-29","current":-1.110608,"twenty":-7.344246,"median":-5.209735,"eighty":-1.243837,"marketCap":3571763722},{"date":"2021-11-05","current":-1.185709,"twenty":-7.286384,"median":-5.095321,"eighty":-1.23286,"marketCap":3819578400},{"date":"2021-11-12","current":-1.094235,"twenty":-7.241474,"median":-5.009016,"eighty":-1.224738,"marketCap":3539440069},{"date":"2021-11-19","current":-1.097454,"twenty":-7.225855,"median":-4.984431,"eighty":-1.219748,"marketCap":3544827344},{"date":"2021-11-26","current":-1.053751,"twenty":-7.205178,"median":-4.944163,"eighty":-1.216265,"marketCap":3404758179},{"date":"2021-12-03","current":-1.018171,"twenty":-7.169298,"median":-4.903998,"eighty":-1.200406,"marketCap":3295877720},{"date":"2021-12-10","current":-0.954682,"twenty":-7.129447,"median":-1.426446,"eighty":-1.169675,"marketCap":3095635560},{"date":"2021-12-17","current":-0.943651,"twenty":-7.111043,"median":-1.362328,"eighty":-1.136822,"marketCap":3057751908},{"date":"2021-12-24","current":-0.949425,"twenty":-7.072786,"median":-1.350385,"eighty":-1.102404,"marketCap":3079399709},{"date":"2021-12-31","current":-0.950348,"twenty":-7.038905,"median":-1.339272,"eighty":-1.097778,"marketCap":3089097489},{"date":"2022-01-07","current":-0.878657,"twenty":-0.948135,"median":-0.941496,"eighty":-0.9181,"marketCap":2845221372},{"date":"2022-01-14","current":-0.885096,"twenty":-0.944413,"median":-0.917914,"eighty":-0.886143,"marketCap":2872318718},{"date":"2022-01-21","current":-0.888074,"twenty":-0.941717,"median":-0.899183,"eighty":-0.883358,"marketCap":2888577126},{"date":"2022-01-28","current":-0.806824,"twenty":-0.939851,"median":-0.888731,"eighty":-0.877567,"marketCap":2617603662},{"date":"2022-02-04","current":-0.828946,"twenty":-0.938755,"median":-0.887458,"eighty":-0.875494,"marketCap":2688056762},{"date":"2022-02-11","current":-0.812264,"twenty":-0.930712,"median":-0.881959,"eighty":-0.828923,"marketCap":2639281539},{"date":"2022-02-18","current":-0.853108,"twenty":-0.930026,"median":-0.8785,"eighty":-0.814042,"marketCap":2785607209},{"date":"2022-02-25","current":-0.77816,"twenty":-0.905116,"median":-0.875494,"eighty":-0.806824,"marketCap":2547150561},{"date":"2022-03-04","current":-0.726557,"twenty":-0.899183,"median":-0.844547,"eighty":-0.779823,"marketCap":2379147013},{"date":"2022-03-11","current":-0.646436,"twenty":-0.895526,"median":-0.828923,"eighty":-0.762198,"marketCap":2113593019},{"date":"2022-03-18","current":-0.564152,"twenty":-0.889387,"median":-0.819539,"eighty":-0.739741,"marketCap":1837200085},{"date":"2022-03-25","current":-0.703485,"twenty":-0.888074,"median":-0.812264,"eighty":-0.703485,"marketCap":1842619555},{"date":"2022-04-01","current":-0.723315,"twenty":-0.886841,"median":-0.805774,"eighty":-0.705389,"marketCap":1896814248},{"date":"2022-04-08","current":-0.756053,"twenty":-0.885445,"median":-0.789745,"eighty":-0.707685,"marketCap":1983525756},{"date":"2022-04-14","current":-0.763513,"twenty":-0.883214,"median":-0.778992,"eighty":-0.710784,"marketCap":1999784164},{"date":"2022-04-22","current":-0.864507,"twenty":-0.881475,"median":-0.785013,"eighty":-0.715858,"marketCap":2221982404},{"date":"2022-04-29","current":-0.970799,"twenty":-0.887581,"median":-0.799657,"eighty":-0.72186,"marketCap":2455019583},{"date":"2022-05-06","current":-0.894652,"twenty":-0.893599,"median":-0.806824,"eighty":-0.723249,"marketCap":2243660281},{"date":"2022-05-13","current":-0.921953,"twenty":-0.895526,"median":-0.812264,"eighty":-0.723315,"marketCap":2270757628},{"date":"2022-05-20","current":-0.974294,"twenty":-0.910588,"median":-0.819539,"eighty":-0.723481,"marketCap":2433341706},{"date":"2022-05-27","current":-0.933875,"twenty":-0.928454,"median":-0.828923,"eighty":-0.725755,"marketCap":2330371790},{"date":"2022-06-02","current":-0.894326,"twenty":-0.923253,"median":-0.835986,"eighty":-0.726397,"marketCap":2243660281},{"date":"2022-06-10","current":-0.930827,"twenty":-0.923253,"median":-0.856924,"eighty":-0.731634,"marketCap":2319532851},{"date":"2022-06-17","current":-0.903545,"twenty":-0.921235,"median":-0.864507,"eighty":-0.733504,"marketCap":2249079751},{"date":"2022-06-24","current":-0.895625,"twenty":-0.920209,"median":-0.877373,"eighty":-0.73612,"marketCap":2238240812},{"date":"2022-06-30","current":-0.86893,"twenty":-0.918264,"median":-0.8785,"eighty":-0.738539,"marketCap":2167787712},{"date":"2022-07-08","current":-0.835485,"twenty":-0.914461,"median":-0.875494,"eighty":-0.739807,"marketCap":2086495672},{"date":"2022-07-15","current":-0.766636,"twenty":-0.911461,"median":-0.86641,"eighty":-0.745027,"marketCap":1896814248},{"date":"2022-07-22","current":-0.777078,"twenty":-0.910608,"median":-0.864141,"eighty":-0.749511,"marketCap":1923911594},{"date":"2022-07-29","current":-0.699612,"twenty":-0.908084,"median":-0.850218,"eighty":-0.739807,"marketCap":1734230169},{"date":"2022-08-05","current":-0.67948,"twenty":-0.905635,"median":-0.844394,"eighty":-0.730365,"marketCap":1680035476},{"date":"2022-08-12","current":-0.678555,"twenty":-0.904683,"median":-0.835735,"eighty":-0.723282,"marketCap":1680035476},{"date":"2022-08-19","current":-0.667728,"twenty":-0.904379,"median":-0.828923,"eighty":-0.714111,"marketCap":1636679722},{"date":"2022-08-26","current":-4.806912,"twenty":-0.905635,"median":-0.828934,"eighty":-0.710784,"marketCap":1663777068},{"date":"2022-09-02","current":-4.635664,"twenty":-0.914461,"median":-0.835986,"eighty":-0.714111,"marketCap":1598743437},{"date":"2022-09-09","current":-4.574508,"twenty":-0.924553,"median":-0.844737,"eighty":-0.71727,"marketCap":1571646091},{"date":"2022-09-16","current":-4.489802,"twenty":-0.930781,"median":-0.850218,"eighty":-0.719565,"marketCap":1528290336},{"date":"2022-09-23","current":-4.399117,"twenty":-0.936913,"median":-0.864141,"eighty":-0.72186,"marketCap":1468676174},{"date":"2022-09-30","current":-4.22871,"twenty":-0.945594,"median":-0.86641,"eighty":-0.723266,"marketCap":1414481482},{"date":"2022-10-07","current":-4.212749,"twenty":-0.957925,"median":-0.872212,"eighty":-0.723348,"marketCap":1409062012},{"date":"2022-10-14","current":-3.963134,"twenty":-0.977792,"median":-0.878343,"eighty":-0.723936,"marketCap":1311511565},{"date":"2022-10-21","current":-3.776097,"twenty":-3.22444,"median":-0.880262,"eighty":-0.725915,"marketCap":1241058465},{"date":"2022-10-28","current":-3.485255,"twenty":-3.54655,"median":-0.882248,"eighty":-0.727826,"marketCap":1143508018},{"date":"2022-11-04","current":-3.533461,"twenty":-3.564976,"median":-0.885968,"eighty":-0.733053,"marketCap":1170605364},{"date":"2022-11-11","current":-3.372537,"twenty":-3.564976,"median":-0.888074,"eighty":-0.73427,"marketCap":1127249610},{"date":"2022-11-18","current":-4.165083,"twenty":-3.664513,"median":-0.889975,"eighty":-0.737337,"marketCap":1387384135},{"date":"2022-11-25","current":-3.837592,"twenty":-3.826592,"median":-0.89328,"eighty":-0.739763,"marketCap":1268155811},{"date":"2022-12-02","current":-3.915115,"twenty":-3.835659,"median":-0.894489,"eighty":-0.740979,"marketCap":1316102460},{"date":"2022-12-09","current":-5.28966,"twenty":-3.895149,"median":-0.895625,"eighty":-0.746088,"marketCap":1794685173},{"date":"2022-12-16","current":-5.366293,"twenty":-3.957486,"median":-0.89931,"eighty":-0.748822,"marketCap":1816438933},{"date":"2022-12-23","current":-4.657906,"twenty":-4.142029,"median":-0.902035,"eighty":-0.75073,"marketCap":1577147576},{"date":"2022-12-30","current":-4.792423,"twenty":-4.178051,"median":-0.902522,"eighty":-0.752323,"marketCap":1642408855},{"date":"2023-01-06","current":-5.104963,"twenty":-4.218565,"median":-0.903172,"eighty":-0.754773,"marketCap":1767492974},{"date":"2023-01-13","current":-6.473381,"twenty":-4.29261,"median":-0.904394,"eighty":-0.756301,"marketCap":2284144766},{"date":"2023-01-20","current":-7.337813,"twenty":-4.41406,"median":-0.908501,"eighty":-0.759905,"marketCap":2566943642},{"date":"2023-01-27","current":-8.781814,"twenty":-4.45269,"median":-0.910613,"eighty":-0.762198,"marketCap":3072718554},{"date":"2023-02-03","current":-10.159166,"twenty":-4.476692,"median":-0.917109,"eighty":-0.763513,"marketCap":3573055027},{"date":"2023-02-10","current":-8.12046,"twenty":-4.51919,"median":-0.921504,"eighty":-0.763975,"marketCap":2838865638},{"date":"2023-02-17","current":-6.957309,"twenty":-4.532548,"median":-0.930026,"eighty":-0.765116,"marketCap":2409228884},{"date":"2023-02-24","current":-7.011621,"twenty":-4.608841,"median":-0.931769,"eighty":-0.766636,"marketCap":2398352004},{"date":"2023-03-03","current":-6.713938,"twenty":-4.658578,"median":-0.934151,"eighty":-0.772954,"marketCap":2311336966},{"date":"2023-03-10","current":-6.525137,"twenty":-6.576065,"median":-6.502751,"eighty":-6.43083,"marketCap":2229760367},{"date":"2023-03-17","current":-6.304985,"twenty":-6.471205,"median":-1.279457,"eighty":-0.866107,"marketCap":2175375968},{"date":"2023-03-24","current":-5.890579,"twenty":-6.454738,"median":-1.294903,"eighty":-0.868328,"marketCap":2055730289},{"date":"2023-03-31","current":-4.546405,"twenty":-6.434164,"median":-1.317657,"eighty":-0.870243,"marketCap":2115553128},{"date":"2023-04-06","current":-4.654594,"twenty":-6.431854,"median":-1.322729,"eighty":-0.874181,"marketCap":2164499088},{"date":"2023-04-14","current":-4.836937,"twenty":-6.386352,"median":-1.330122,"eighty":-0.876039,"marketCap":2251514126},{"date":"2023-04-21","current":-4.290023,"twenty":-6.325603,"median":-1.34829,"eighty":-0.877567,"marketCap":1995907450},{"date":"2023-04-28","current":-4.392868,"twenty":-6.281321,"median":-1.35979,"eighty":-0.878531,"marketCap":2028538090},{"date":"2023-05-05","current":-4.409192,"twenty":-6.256969,"median":-1.375614,"eighty":-0.879104,"marketCap":2039414970},{"date":"2023-05-12","current":-4.214816,"twenty":-6.243739,"median":-3.359621,"eighty":-0.880164,"marketCap":1936084611},{"date":"2023-05-19","current":-3.734559,"twenty":-6.215891,"median":-3.416131,"eighty":-0.881234,"marketCap":1691354815},{"date":"2023-05-25","current":-3.629412,"twenty":-6.170436,"median":-3.439156,"eighty":-0.882017,"marketCap":1636970415},{"date":"2023-06-02","current":-3.085213,"twenty":-6.133258,"median":-3.428289,"eighty":-0.882274,"marketCap":1386802179},{"date":"2023-06-09","current":-4.107444,"twenty":-6.050381,"median":-3.439156,"eighty":-0.88292,"marketCap":1843631132},{"date":"2023-06-16","current":-4.882039,"twenty":-6.011145,"median":-3.447681,"eighty":-0.885445,"marketCap":2180814407},{"date":"2023-06-23","current":-4.357948,"twenty":-5.95515,"median":-3.493084,"eighty":-0.886841,"marketCap":1936084611},{"date":"2023-06-30","current":-4.558321,"twenty":-5.952914,"median":-3.518177,"eighty":-0.887125,"marketCap":2006784330},{"date":"2023-07-07","current":-4.579608,"twenty":-5.934117,"median":-3.531771,"eighty":-0.888074,"marketCap":2012222770},{"date":"2023-07-14","current":-4.577264,"twenty":-5.890579,"median":-3.551008,"eighty":-0.888797,"marketCap":2039414970},{"date":"2023-07-21","current":-4.709004,"twenty":-5.884721,"median":-3.629412,"eighty":-0.889387,"marketCap":2088360929},{"date":"2023-07-28","current":-4.664945,"twenty":-5.527476,"median":-3.664851,"eighty":-0.890562,"marketCap":2066607169},{"date":"2023-08-04","current":-4.804272,"twenty":-5.374532,"median":-3.734559,"eighty":-0.892422,"marketCap":2131868448},{"date":"2023-08-11","current":-4.400164,"twenty":-5.366293,"median":-3.777004,"eighty":-0.89328,"marketCap":1941523051},{"date":"2023-08-18","current":-4.518795,"twenty":-5.28966,"median":-3.821254,"eighty":-0.893316,"marketCap":1979592130},{"date":"2023-08-25","current":-3.832104,"twenty":-5.278932,"median":-3.830016,"eighty":-0.894326,"marketCap":1979592130},{"date":"2023-09-01","current":-3.858195,"twenty":-5.276931,"median":-3.837592,"eighty":-0.894652,"marketCap":2001345890},{"date":"2023-09-08","current":-3.713193,"twenty":-5.237799,"median":-3.824591,"eighty":-0.895526,"marketCap":1903453972},{"date":"2023-09-15","current":-3.495129,"twenty":-5.225604,"median":-3.802288,"eighty":-0.895625,"marketCap":1805562053},{"date":"2023-09-22","current":-3.521051,"twenty":-5.196615,"median":-3.777004,"eighty":-0.898562,"marketCap":1811000493},{"date":"2023-09-29","current":-3.789469,"twenty":-5.193866,"median":-3.73711,"eighty":-0.899183,"marketCap":1952399931},{"date":"2023-10-06","current":-4.150349,"twenty":-5.186145,"median":-3.77791,"eighty":-0.899387,"marketCap":2137306888},{"date":"2023-10-13","current":-4.262322,"twenty":-5.170056,"median":-3.798805,"eighty":-0.900759,"marketCap":2191691287},{"date":"2023-10-20","current":-4.237121,"twenty":-5.130505,"median":-3.821254,"eighty":-0.901846,"marketCap":2175375968},{"date":"2023-10-27","current":-4.270731,"twenty":-5.111579,"median":-3.832104,"eighty":-0.902298,"marketCap":2191691287},{"date":"2023-11-03","current":-4.354545,"twenty":-5.099178,"median":-3.850418,"eighty":-0.902532,"marketCap":2240637247},{"date":"2023-11-10","current":-4.355455,"twenty":-5.082078,"median":-3.866043,"eighty":-0.902707,"marketCap":2240637247},{"date":"2023-11-17","current":-4.452726,"twenty":-5.059256,"median":-3.884467,"eighty":-0.903246,"marketCap":2311336966},{"date":"2023-11-24","current":-4.405976,"twenty":-5.03676,"median":-3.889155,"eighty":-0.904039,"marketCap":2305898526},{"date":"2023-12-01","current":-4.346388,"twenty":-5.025942,"median":-3.898718,"eighty":-0.904384,"marketCap":2284144766},{"date":"2023-12-08","current":-4.228949,"twenty":-5.009914,"median":-3.934894,"eighty":-0.904827,"marketCap":2213445047},{"date":"2023-12-15","current":-4.173677,"twenty":-4.996122,"median":-3.993196,"eighty":-0.905895,"marketCap":2197129727},{"date":"2023-12-22","current":-4.073088,"twenty":-4.988892,"median":-4.055159,"eighty":-0.908918,"marketCap":2142745328},{"date":"2023-12-29","current":-4.061769,"twenty":-4.985569,"median":-4.058464,"eighty":-0.910598,"marketCap":2148183768},{"date":"2024-01-05","current":-3.036713,"twenty":-4.984431,"median":-4.044717,"eighty":-0.910638,"marketCap":1594726382},{"date":"2024-01-12","current":-3.055886,"twenty":-4.982754,"median":-3.984826,"eighty":-0.912695,"marketCap":1605649165},{"date":"2024-01-19","current":-2.924778,"twenty":-4.961865,"median":-3.944909,"eighty":-0.917109,"marketCap":1534651073},{"date":"2024-01-26","current":-3.186986,"twenty":-4.959787,"median":-3.915115,"eighty":-0.919997,"marketCap":1665724474},{"date":"2024-02-02","current":-2.123882,"twenty":-4.94146,"median":-3.893827,"eighty":-0.920505,"marketCap":1108662519},{"date":"2024-02-09","current":-1.707436,"twenty":-4.928539,"median":-3.884949,"eighty":-0.921056,"marketCap":895668242},{"date":"2024-02-16","current":-1.831974,"twenty":-4.924677,"median":-3.884467,"eighty":-0.921594,"marketCap":961204942},{"date":"2024-02-23","current":-1.778899,"twenty":-4.92111,"median":-3.866043,"eighty":-0.92225,"marketCap":928436592},{"date":"2024-03-01","current":-1.704587,"twenty":-4.919466,"median":-3.850418,"eighty":-0.924059,"marketCap":890206850},{"date":"2024-03-08","current":-1.724736,"twenty":-4.914432,"median":-3.832104,"eighty":-0.927126,"marketCap":901129633},{"date":"2024-03-15","current":-1.673952,"twenty":-4.908038,"median":-3.820364,"eighty":-0.929397,"marketCap":873822675},{"date":"2024-03-22","current":-1.727844,"twenty":-4.904688,"median":-3.795321,"eighty":-0.930438,"marketCap":901129633},{"date":"2024-03-28","current":-2.069516,"twenty":-4.903627,"median":-3.77791,"eighty":-0.930758,"marketCap":862899891},{"date":"2024-04-05","current":-2.044667,"twenty":-4.90307,"median":-3.756603,"eighty":-0.930827,"marketCap":851977108},{"date":"2024-04-12","current":-2.043506,"twenty":-4.899592,"median":-3.734559,"eighty":-0.932712,"marketCap":851977108},{"date":"2024-04-19","current":-2.032142,"twenty":-4.898192,"median":-3.710917,"eighty":-0.933875,"marketCap":846515716},{"date":"2024-04-26","current":-1.982143,"twenty":-4.882039,"median":-3.698022,"eighty":-0.934151,"marketCap":824670149},{"date":"2024-05-03","current":-1.99665,"twenty":-4.879727,"median":-3.659343,"eighty":-0.935839,"marketCap":830131541},{"date":"2024-05-10","current":-2.04434,"twenty":-4.869708,"median":-3.621493,"eighty":-0.938256,"marketCap":851977108},{"date":"2024-05-17","current":-2.086717,"twenty":-4.854248,"median":-3.586229,"eighty":-0.939759,"marketCap":868361283},{"date":"2024-05-24","current":-1.9468,"twenty":-4.840368,"median":-3.574134,"eighty":-0.941069,"marketCap":808285974},{"date":"2024-05-31","current":-1.971101,"twenty":-4.818922,"median":-3.555282,"eighty":-0.941828,"marketCap":819208758},{"date":"2024-06-07","current":-1.934078,"twenty":-4.805328,"median":-3.549379,"eighty":-0.942219,"marketCap":802824582},{"date":"2024-06-14","current":-1.843669,"twenty":-4.801063,"median":-3.533461,"eighty":-0.94286,"marketCap":764594840},{"date":"2024-06-21","current":-1.860733,"twenty":-4.794719,"median":-3.522587,"eighty":-0.945374,"marketCap":770056232},{"date":"2024-06-28","current":-1.861505,"twenty":-4.791838,"median":-3.514149,"eighty":-0.948135,"marketCap":770056232},{"date":"2024-07-05","current":-1.86191,"twenty":-4.789647,"median":-3.495129,"eighty":-0.948605,"marketCap":770056232},{"date":"2024-07-12","current":-1.872364,"twenty":-4.782461,"median":-3.480262,"eighty":-0.94961,"marketCap":775517624},{"date":"2024-07-19","current":-1.780031,"twenty":-4.774051,"median":-3.447681,"eighty":-0.950401,"marketCap":737287882},{"date":"2024-07-26","current":-1.773442,"twenty":-4.769374,"median":-3.444602,"eighty":-0.951426,"marketCap":737287882},{"date":"2024-08-02","current":-1.800765,"twenty":-4.75935,"median":-3.43022,"eighty":-0.955027,"marketCap":748210665},{"date":"2024-08-09","current":-1.736613,"twenty":-4.749482,"median":-3.411491,"eighty":-0.957089,"marketCap":726365098},{"date":"2024-08-16","current":-1.814253,"twenty":-4.742241,"median":-3.372537,"eighty":-0.960131,"marketCap":759133449},{"date":"2024-08-23","current":-1.79362,"twenty":-4.734722,"median":-3.245622,"eighty":-0.962052,"marketCap":753672057},{"date":"2024-08-30","current":-3.065013,"twenty":-4.715613,"median":-3.157916,"eighty":-0.964855,"marketCap":764594840},{"date":"2024-09-06","current":-2.976009,"twenty":-4.71083,"median":-3.126037,"eighty":-0.96642,"marketCap":742749273},{"date":"2024-09-13","current":-3.005759,"twenty":-4.708887,"median":-3.103102,"eighty":-0.971498,"marketCap":748210665},{"date":"2024-09-20","current":-2.987841,"twenty":-4.708419,"median":-3.087932,"eighty":-0.974294,"marketCap":748210665},{"date":"2024-09-27","current":-3.12173,"twenty":-4.707871,"median":-3.084226,"eighty":-0.974609,"marketCap":786440407},{"date":"2024-10-04","current":-3.702192,"twenty":-4.707595,"median":-3.093274,"eighty":-0.976131,"marketCap":928436592},{"date":"2024-10-10","current":-3.30985,"twenty":-4.706208,"median":-3.106283,"eighty":-0.977805,"marketCap":824670149},{"date":"2024-10-18","current":-2.996682,"twenty":-4.705093,"median":-3.103102,"eighty":-0.982305,"marketCap":742749273},{"date":"2024-10-25","current":-3.085015,"twenty":-4.704309,"median":-3.093274,"eighty":-0.985043,"marketCap":764594840},{"date":"2024-11-01","current":-3.104958,"twenty":-4.696158,"median":-3.098617,"eighty":-0.994297,"marketCap":770056232},{"date":"2024-11-08","current":-3.128664,"twenty":-4.689408,"median":-3.095,"eighty":-1.010816,"marketCap":770056232},{"date":"2024-11-15","current":-3.130131,"twenty":-4.686,"median":-3.103102,"eighty":-1.018026,"marketCap":764594840},{"date":"2024-11-22","current":-3.019771,"twenty":-4.678603,"median":-3.089657,"eighty":-1.02929,"marketCap":737287882},{"date":"2024-11-29","current":-3.021798,"twenty":-4.673214,"median":-3.085416,"eighty":-1.040457,"marketCap":737287882},{"date":"2024-12-06","current":-3.006496,"twenty":-4.667853,"median":-3.084973,"eighty":-1.049435,"marketCap":731826490},{"date":"2024-12-13","current":-3.009239,"twenty":-4.661125,"median":-3.083926,"eighty":-1.054874,"marketCap":731826490},{"date":"2024-12-20","current":-2.912945,"twenty":-4.658175,"median":-3.064917,"eighty":-1.062519,"marketCap":704519531},{"date":"2024-12-27","current":-2.892607,"twenty":-4.657244,"median":-3.062897,"eighty":-1.067235,"marketCap":699058140},{"date":"2025-01-03","current":-2.912355,"twenty":-4.654594,"median":-3.052268,"eighty":-1.067706,"marketCap":704519531},{"date":"2025-01-10","current":-2.968757,"twenty":-4.653326,"median":-3.044604,"eighty":-1.067807,"marketCap":715442315},{"date":"2025-01-17","current":-3.170158,"twenty":-4.651833,"median":-3.046231,"eighty":-1.078135,"marketCap":764594840},{"date":"2025-01-24","current":-3.105412,"twenty":-4.641376,"median":-3.059392,"eighty":-1.08636,"marketCap":753672057},{"date":"2025-01-28","current":-3.113051,"twenty":-4.639091,"median":-3.063859,"eighty":-1.087285,"marketCap":759133449},{"date":"2025-02-07","current":-3.084287,"twenty":-4.634825,"median":-3.055886,"eighty":-1.089022,"marketCap":748210665},{"date":"2025-02-14","current":-4.016916,"twenty":-4.62651,"median":-3.064917,"eighty":-1.091165,"marketCap":972127726},{"date":"2025-02-21","current":-4.017449,"twenty":-4.613092,"median":-3.083238,"eighty":-1.09385,"marketCap":977589117},{"date":"2025-02-28","current":-3.692962,"twenty":-4.603857,"median":-3.084286,"eighty":-1.09444,"marketCap":895668242},{"date":"2025-03-07","current":-4.709882,"twenty":-4.62651,"median":-3.085015,"eighty":-1.09583,"marketCap":1146892261},{"date":"2025-03-14","current":-4.394291,"twenty":-4.613092,"median":-3.085552,"eighty":-1.098102,"marketCap":1070432777},{"date":"2025-03-21","current":-4.597876,"twenty":-4.609803,"median":-3.087932,"eighty":-1.099749,"marketCap":1119585302},{"date":"2025-03-28","current":-4.189974,"twenty":-4.609803,"median":-3.100859,"eighty":-1.101379,"marketCap":1064971385},{"date":"2025-04-03","current":-3.973722,"twenty":-4.606648,"median":-3.105185,"eighty":-1.102354,"marketCap":1010357468},{"date":"2025-04-11","current":-3.120992,"twenty":-4.597577,"median":-3.105412,"eighty":-1.104164,"marketCap":786440407},{"date":"2025-04-17","current":-3.246731,"twenty":-4.596382,"median":-3.113051,"eighty":-1.110608,"marketCap":819208758},{"date":"2025-04-25","current":-3.758926,"twenty":-4.595588,"median":-3.119453,"eighty":-1.112934,"marketCap":950282159},{"date":"2025-05-02","current":-3.664725,"twenty":-4.591307,"median":-3.12173,"eighty":-1.127413,"marketCap":928436592},{"date":"2025-05-09","current":-3.532143,"twenty":-4.587924,"median":-3.128664,"eighty":-1.136822,"marketCap":901129633},{"date":"2025-05-16","current":-4.586425,"twenty":-4.58673,"median":-3.134034,"eighty":-1.140494,"marketCap":1179660611},{"date":"2025-05-23","current":-4.742109,"twenty":-4.595985,"median":-3.13735,"eighty":-1.149465,"marketCap":1223351745},{"date":"2025-05-30","current":-5.775224,"twenty":-4.613734,"median":-3.145511,"eighty":-1.15994,"marketCap":1496421331},{"date":"2025-06-06","current":-6.32817,"twenty":-4.64765,"median":-3.15015,"eighty":-1.169675,"marketCap":1643878907},{"date":"2025-06-13","current":-6.241607,"twenty":-4.658309,"median":-3.155738,"eighty":-1.178376,"marketCap":1622033340},{"date":"2025-06-20","current":-5.727446,"twenty":-4.680547,"median":-3.170158,"eighty":-1.18604,"marketCap":1485498547},{"date":"2025-06-27","current":-5.270494,"twenty":-4.6978,"median":-3.184602,"eighty":-1.191828,"marketCap":1370809321},{"date":"2025-07-04","current":-5.291243,"twenty":-4.705251,"median":-3.194283,"eighty":-1.200086,"marketCap":1376270713},{"date":"2025-07-11","current":-5.632869,"twenty":-4.708887,"median":-3.209013,"eighty":-1.202818,"marketCap":1463652980},{"date":"2025-07-18","current":-6.373499,"twenty":-4.731353,"median":-3.249828,"eighty":-1.210023,"marketCap":1654801691},{"date":"2025-07-25","current":-6.455197,"twenty":-4.749482,"median":-3.292817,"eighty":-1.215674,"marketCap":1682108649},{"date":"2025-08-01","current":-6.03138,"twenty":-4.782461,"median":-3.340366,"eighty":-1.216112,"marketCap":1561958031},{"date":"2025-08-05","current":-7.576628,"twenty":-4.791545,"median":-3.344795,"eighty":-1.216417,"marketCap":1966101019}],"updateTime":1754498181369}}}